Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fentanyl TAIFUN for breakthrough cancer pain
2005-002544-25Phase 2Completed
- Sponsor
- LAB Pharma
- Start
- Jul 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, double-blind trial of fentanyl in cancer pain and breakthrough pain (2 arms), sponsored by LAB Pharma. Primary endpoints: Time to significant pain relief, Proportion of subjects reaching successful titration and 1 more. Started Jul 2005; status: completed.
02
Drugs
fentanyl
03
Conditions
cancer painbreakthrough pain
Beyond the preview
Go deeper on 2005-002544-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002544-25.